TM-29

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameTM-29
Drug Alias NameTCAR monoclonal TM 29
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionImmunosuppressantsAntibody-dependent cell-mediated cytotoxicity (ADCC) effectsT lymphocytes inhibitors
TargetsUpdating
Therapy Area/IndicationsAutoimmune DiseasesCrohn DiseaseNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSweden
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAvant Immunotherapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAvant Immunotherapeutics
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesCrohn DiseaseNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A